High-resolution molecular karyotyping in patients with developmental delay and/or multiple congenital anomalies in a clinical setting

Clinical Genetics

Volumn 79, Issue 2, 2011, Pages 147-157

  Wincent, J ^a   Anderlid, B M ^a   Lagerberg, M ^a   Nordenskjold M ^a   Schoumans, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Agilent array; Array CGH; BAC array; Developmental delay; Multiple congenital anomalies

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHILD; COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL MALFORMATION; COPY NUMBER VARIATION; DEVELOPMENTAL DISORDER; DIAGNOSTIC TEST; DISEASE SEVERITY; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC SCREENING; HUMAN; INFANT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NEWBORN; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; FEMALE; GENETIC TESTING; HUMANS; INFANT; INFANT, NEWBORN; KARYOTYPING; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 78650895100     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01442.x     Document Type: Article

References (31)

1. Stankiewicz P, Beaudet AL. Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. Curr Opin Genet Dev 2007: 17: 182-192.
2. Darilek S, Ward P, Pursley A et al. Pre- and postnatal genetic testing by array-comparative genomic hybridization: genetic counseling perspectives. Genet Med 2008: 10: 13-18.
3. Shaffer LG. American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation. Genet Med 2005: 7: 650-654.
4. Rauch A, Hoyer J, Guth S et al. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet 2006: 140: 2063-2074.
5. van Karnebeek CD, Jansweijer MC, Leenders AG et al. Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness. Eur J Hum Genet 2005: 13: 6-25.
6. Menten B, Maas N, Thienpont B et al. Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J Med Genet 2006: 43: 625-633.
7. Shaffer LG, Bejjani BA, Torchia B et al. The identification of microdeletion syndromes and other chromosome abnormalities: cytogenetic methods of the past, new technologies for the future. Am J Med Genet C Semin Med Genet 2007: 145C: 335-345.
8. Sagoo GS, Butterworth AS, Sanderson S et al. Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13, 926 subjects. Genet Med 2009: 11: 139-146.
9. Slavotinek AM. Novel microdeletion syndromes detected by chromosome microarrays. Hum Genet 2008: 124: 1-17.
10. Lee C, Iafrate AJ, Brothman AR. Copy number variations and clinical cytogenetic diagnosis of constitutional disorders. Nat Genet 2007: 39: S48-S54.
11. Redon R, Ishikawa S, Fitch KR et al. Global variation in copy number in the human genome. Nature 2006: 444: 444-454.
12. Schoumans J, Ruivenkamp C, Holmberg E et al. Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH). J Med Genet 2005: 42: 699-705.
13. Schoumans J, Staaf J, Jonsson G et al. Detection and delineation of an unusual 17p11.2 deletion by array-CGH and refinement of the Smith-Magenis syndrome minimum deletion to approximately 650 kb. Eur J Med Genet 2005: 48: 290-300.
14. Zhang ZF, Ruivenkamp C, Staaf J et al. Detection of submicroscopic constitutional chromosome aberrations in clinical diagnostics: a validation of the practical performance of different array platforms. Eur J Hum Genet 2008: 16: 786-792.
15. Bremer A, Schoumans J, Nordenskjold M et al. An interstitial deletion of 7.1Mb in chromosome band 6p22.3 associated with developmental delay and dysmorphic features including heart defects, short neck, and eye abnormalities. Eur J Med Genet 2009: 52: 358-362.
16. Jonsson G, Staaf J, Olsson E et al. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization. Genes Chromosomes Cancer 2007: 46: 543-558.
17. Schoumans J, Johansson B, Corcoran M et al. Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2. Br J Haematol 2006: 135: 492-499.
18. Saal LH, Troein C, Vallon-Christersson J et al. BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol 2002: 3: SOFTWARE0003.
19. Hupe P, Stransky N, Thiery JP et al. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 2004: 20: 3413-3422.
20. Fan YS, Jayakar P, Zhu H et al. Detection of pathogenic gene copy number variations in patients with mental retardation by genomewide oligonucleotide array comparative genomic hybridization. Hum Mutat 2007: 28: 1124-1132.
21. Barbaro M, Oscarson M, Schoumans J et al. Isolated 46, XY gonadal dysgenesis in two sisters caused by a Xp21.2 interstitial duplication containing the DAX1 gene. J Clin Endocrinol Metab 2007: 92: 3305-3313.
22. Friedman JI, Vrijenhoek T, Markx S et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 2008: 13: 261-266.
23. Poot M, Beyer V, Schwaab I et al. Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder. Neurogenetics 2009: 11 (1): 81-89.
24. Belloso JM, Bache I, Guitart M et al. Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome. Eur J Hum Genet 2007: 15: 711-713.
25. Strauss KA, Puffenberger EG, Huentelman MJ et al. Recessive symptomatic focal epilepsy and mutant contact in-associated protein-like 2. N Engl J Med 2006: 354: 1370-1377.
26. Ullmann R, Turner G, Kirchhoff M et al. Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation. Hum Mutat 2007: 28: 674-682.
27. de Kovel CG, Trucks H, Helbig I et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 2010: 133: 23-32.
28. Mefford HC, Cooper GM, Zerr T et al. A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease. Genome Res 2009: 19: 1579-1585.
29. Hannes FD, Sharp AJ, Mefford HC et al. Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet 2009: 46: 223-232.
30. Coppinger J, McDonald-McGinn D, Zackai E et al. Identification of familial and de novo microduplications of 22q11.21-q11.23 distal to the 22q11.21 microdeletion syndrome region. Hum Mol Genet 2009: 18: 1377-1383.
31. Descartes M, Franklin J, de Stahl TD et al. Distal 22q11.2 microduplication encompassing the BCR gene. Am J Med Genet 2008: 146A: 3075-3081.